Ahmed will take over the new role following closure of the deal, expected in the first half of 2015
India's premier medical institute to collaborate with Osaka University for low-cost surgical devices research
The collaboration is a sales and distribution arrangement whereby Cipla Medpro will exclusively market Teva's broad pharmaceutical product portfolio in South Africa
Colorcon will use BASF's coating polymer Kollicoat IR, an ethylene glycol and vinyl alcohol graft copolymer, for its fully formulated ready-to-use coatings
The company hopes to have a portfolio of around 15 products in the market in a couple of years
Drugs are highly sensitive to temperature fluctuations. Phase change materials can offer cost-effective, energy-efficient solutions for transporting medicines
Merck Serono will make milestone payments based on achieving regulatory and sales goals plus royalty payments on net sales of future products developed under the agreement
This is part of the company's strategy to expand its business in Asian countries
The company has licensed this drug from Cipher Pharmaceuticals Inc
With this Bayer becomes one of the leading players in the global OTC (over-the-counter) market
The company is also eyeing to expand its operations to the neighbouring countries and tie up with various State governments in India in near future
Merger is expected to create a vertically integrated pharma company with strong presence in formulations, branded generics, APIs and CRAMS
As part of its exercise, the company recently introduced its own office in Kenya
As a part of deal, GMS Holdings will aquire 25% stake in Stelis Biopharma
The Tarapur plant has facilities for production of tablets, capsules and dry syrups
The company is holding talks with various pharmaceutical firms for tie-ups to market Trois in Singapore
The Hong Kong based VitaPac focuses on active sorbents and has built up a leading market position for desiccant packets for moisture adsorption
The UN arm has signed the deal with India's Aurobindo, Cipla, Emcure, Hetero Labs and Laurus Labs for Gilead Sciences' tenofovir alafenamide
While the company will stop manufacturing vanaspati/edible oils, it will sell trademarks and copyrights related to 'Rasoi' brand to Emami Biotech Ltd for Rs 13 crores
The company recently hosted Innovation Day in Mumbai to promote collaboration with user-industries